CDx news
Exploring HLA in tumors: Introduction to HLA in healthy tissue and the tumor microenvironment
HLA plays an important role in the immune system and is more and more leveraged in HLA-restricted precision medicine therapies, […]
NGS vs Sanger-based HLA typing for Companion Diagnostics: key differences and clinical implications
While still emerging in clinical practice, HLA-restricted therapies are gaining traction in clinical research and early-stage precision medicine applications (see […]
The role of HLA in immunotherapy development
Human Leukocyte Antigen (HLA) proteins have long been central in the transplantation field, because of their critical role on transplant […]
GenDx and Treos Bio Announce Partnership to develop HLA-based Companion Diagnostic for PolyPEPI1018 Cancer Immunotherapy
PRESS RELEASE Utrecht and London, 17 March 2026 GenDx, a Eurobio Scientific Company, based in the Netherlands, specialized in molecular […]
Navigating Grey Zones & Growing Pains: Developments in the Regulatory CDx Space
About The tremendous advances in the Precision Medicine field are shifting the focus of treatment towards more precise and targeted […]
Supporting Precision Medicine: Our Companion Diagnostics (CDx) services
We are excited to share that GenDx updated its website to better showcase our comprehensive Companion Diagnostics (CDx) services. Our […]
